Pfizer Inc.
30.03USD
-0.3900 (-1.28%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on PFE.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.73▼ | $0.82 | 1 | 6 |
| Next quarter | $0.71▲ | $0.7 | 4 | 4 |
| Current year | $2.96▲ | $2.95 | 1 | 4 |
| Next year | $2.88▲ | $2.83 | 2 | 3 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.68 | $0.77 | +0.09 (+12.9%) |
| 2026-03-31 | $0.72 | $0.75 | +0.03 (+3.9%) |
| 2025-12-31 | $0.57 | $0.66 | +0.09 (+16.2%) |
| 2025-09-30 | $0.63 | $0.87 | +0.24 (+37.4%) |
305 ratings from 40 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Neutral | $28 $30 | Oct 9, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $27 $28 | Oct 8, 2026 |
| Scotiabank | Maintained | Sector Outperform | $30 $33 | Oct 6, 2026 |
| HSBC | Maintained | Hold | $28 $30 | Sep 10, 2026 |
| Guggenheim | Maintained | Buy | $35 $31 | Aug 7, 2026 |
| BMO Capital | Maintained | Outperform | $34 $30 | Jul 13, 2026 |
| Guggenheim | Maintained | Buy | $36 $35 | Jul 13, 2026 |
| B of A Securities | Maintained | Neutral | $27 $26 | Jul 10, 2026 |
| JP Morgan | Maintained | Neutral | $30 $28 | Jul 8, 2026 |
| Cantor Fitzgerald | Reiterated | Neutral | $27 | Jul 6, 2026 |
| HSBC | Downgraded from Buy | Hold | $32 $28 | Jul 6, 2026 |
| RBC Capital | Upgraded from Underperform | Sector Perform | $25 | Jun 10, 2026 |
| Citigroup | Maintained | Neutral | $26 $27 | Apr 29, 2026 |
| RBC Capital | Reiterated | Underperform | $25 | Apr 20, 2026 |
| CICC | Initiated | Outperform | $33 | Apr 16, 2026 |
| UBS | Maintained | Neutral | $25 $27 | Apr 13, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $27 $28 | Apr 10, 2026 |
| B of A Securities | Maintained | Neutral | $27 $26 | Apr 9, 2026 |
| Guggenheim | Maintained | Buy | $35 $36 | Mar 24, 2026 |
| HSBC | Maintained | Buy | $29 $32 | Mar 17, 2026 |
| Argus Research | Upgraded from Hold | Buy | $35 | Mar 2, 2026 |
| RBC Capital | Initiated | Underperform | $25 | Feb 25, 2026 |
| Barclays | Initiated | Underweight | $25 | Feb 20, 2026 |
| Freedom Broker | Maintained | Buy | $35 $33 | Feb 9, 2026 |
| Cantor Fitzgerald | Reiterated | Neutral | $27 | Feb 4, 2026 |
44 filings from 17 insiders · 3 buy / 2 sell over 6m
Officers and directors of PFE, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| BOURLA ALBERTDirector; Officer, Chairman & CEO | GrantPhantom Stock Units SSP | 20 | $29.44 | $589 | Oct 15, 2026 |
| BOURLA ALBERTDirector; Officer, Chairman & CEO | GrantPhantom Stock Units SSP | 71 | $28.37 | $2k | Oct 13, 2026 |
| BOURLA ALBERTDirector; Officer, Chairman & CEO | GrantPhantom Stock Units SSP | 21 | $28.52 | $599 | Sep 30, 2026 |
| Buckley Mortimer JDirector | GrantPhantom Stock Units | 1.3k | $28.67 | $37k | Sep 25, 2026 |
| Echevarria JosephDirector | GrantPhantom Stock Units | 1.6k | $28.67 | $46k | Sep 25, 2026 |
| NARAYEN SHANTANUDirector | GrantPhantom Stock Units | 1.7k | $28.67 | $50k | Sep 25, 2026 |
| Quincey JamesDirector | GrantPhantom Stock Units | 1.4k | $28.67 | $39k | Sep 25, 2026 |
| SMITH JAMES CDirector | GrantPhantom Stock Units | 1.6k | $28.67 | $45k | Sep 25, 2026 |
| Taraporevala CyrusDirector | GrantPhantom Stock Units | 1.3k | $28.67 | $37k | Sep 25, 2026 |
| BOURLA ALBERTDirector; Officer, Chairman & CEO | GrantPhantom Stock Units SSP | 22 | $27.55 | $606 | Sep 15, 2026 |
| BOURLA ALBERTDirector; Officer, Chairman & CEO | GrantPhantom Stock Units SSP | 21 | $28.46 | $598 | Aug 31, 2026 |
| BOURLA ALBERTChief Executive Officer | Buy | 38.0k | $26.34 | $1.00M | Aug 12, 2026 |
| BLAYLOCK RONALD EDirector | Buy | 39.2k | $25.46 | $999k | Aug 5, 2026 |
| BUCKLEY MORTIMER J.Director | Buy | 37.6k | $25.52 | $960k | Aug 5, 2026 |
| DAMICO JENNIFER B.Officer | Sell | 3.3k | $25.40 | $83k | Aug 5, 2026 |
| DAMICO JENNIFER B.Officer | Sell | 2.0k | $25.70 | $51k | Jun 9, 2026 |
| DAMICO JENNIFER B.Officer | Grant | 21.7k | — | — | Mar 3, 2026 |
| BOSHOFF CHRISTOFFELOfficer | Grant | 13.4k | — | — | Feb 25, 2026 |
| SAHNI PAYALOfficer | Exercise | 56.9k | $33.82 | $1.92M | Feb 25, 2026 |
| MCDERMOTT MICHAELOfficer | Exercise | 37.9k | $33.82 | $1.28M | Feb 25, 2026 |
No analyst notes on PFE yet.
Analyst Ratings
26 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 8 | 17 | 1 | 1 | Hold2.75 |
| 1 mo ago | 2 | 8 | 16 | 1 | 1 | Hold2.68 |
| 2 mo ago | 2 | 8 | 16 | 1 | 1 | Hold2.68 |
| 3 mo ago | 2 | 8 | 16 | 1 | 1 | Hold2.68 |
Members whose judged calls on PFE have played out most reliably.
No settled calls on PFE yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice